Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CETP | P11597 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | UBE2N | P61088 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL273958 | 0.92 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRDNM1FDPS | |
| SCHEMBL15939023 | 0.91 | LMNA (0.54) | ALDH1A1LMNATSHRFDPSCYP2D6 | |
| SCHEMBL29020574 | 0.91 | LMNA (0.54) | ALDH1A1LMNATSHRFDPSCYP2D6 | |
| SCHEMBL1614491 | 0.90 | ALDH1A1 (0.46) | ALDH1A1LMNATSHRDNM1FDPS | |
| SCHEMBL12348426 | 0.89 | LMNA (0.39) | ALDH1A1LMNATSHRFDPSCYP2D6 | |
| SCHEMBL10876729 | 0.87 | ACE2 (0.41) | ALDH1A1LMNATSHRDNM1FDPS | |
| SCHEMBL10836623 | 0.84 | LMNA (0.52) | ALDH1A1LMNATSHRCYP2D6SPHK1 | |
| SCHEMBL6463333 | 0.84 | ALDH1A1 (0.55) | ALDH1A1LMNATSHRDNM1FDPS | |
| SCHEMBL21879679 | 0.83 | LMNA (0.50) | ALDH1A1LMNATSHRFDPSCYP2D6 | |
| SCHEMBL18124655 | 0.82 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRDNM1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9765003-B2 | Process for producing 2,6-dimethyl-5-hepten-1-al | BASF SE (DE) | 2017-09-19 | — | — | US | disclosed |
| US-20170183280-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2017-06-29 | — | — | US | disclosed |
| EP-3140272-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2017-03-15 | — | — | EP | disclosed |
| WO-2015169721-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | BASF SE (DE) | 2015-11-12 | — | — | WO | disclosed |
| EP-2384317-B1 | METHOD FOR PRODUCING KETONES BY CONVERTING 1.1-DISUBSTITUTED OLEFINES BY MEANS OF N2O | BASF SE (DE) | 2014-04-23 | — | — | EP | disclosed |
| US-8420866-B2 | Process for preparing ketones by reacting 1,1-disubstituted olefins with N2O | BASF SE (DE) | 2013-04-16 | — | — | US | disclosed |
| EP-2384317-A1 | METHOD FOR PRODUCING KETONES BY CONVERTING 1.1-DISUBSTITUTED OLEFINES BY MEANS OF N2O | BASF SE (DE) | 2011-11-09 | — | — | EP | disclosed |
| US-20110269996-A1 | PROCESS FOR PREPARING KETONES BY REACTING 1,1-DISUBSTITUTED OLEFINS WITH N2O | BASF SE (DE) | 2011-11-03 | — | — | US | disclosed |
| WO-2010076182-A1 | METHOD FOR PRODUCING KETONES BY CONVERTING 1.1-DISUBSTITUTED OLEFINES BY MEANS OF N2O | BASF SE (DE) | 2010-07-08 | — | — | WO | disclosed |
| EP-0665223-A1 | Antitumor agent, novel 3(2H)-pyridazinone derivatives and their preparation | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269996-A1 | PROCESS FOR PREPARING KETONES BY REACTING 1,1-DISUBSTITUTED OLEFINS WITH N2O | OXER1, CYP2E1, CYP2F1 | ALDH1A1 526/4885LMNA 3733/4885TSHR 4660/4885 |
| US-20170183280-A1 | PROCESS FOR PRODUCING 2,6-DIMETHYL-5-HEPTEN-1-AL | CYP8B1, CYP51A1, MSMO1 | ALDH1A1 423/4885LMNA 884/4885TSHR 4850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.